Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer
- Resource Type
- article
- Source
- Molecular Cancer, Vol 20, Iss 1, Pp 1-6 (2021)
- Subject
HER2+ breast cancer T-DM1 Liquid biopsy Circulating tumor DNA Pharmacological resistance Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 1476-4598